Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 6 | 2016 | 1051 | 0.690 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2018 | 2473 | 0.530 |
Why?
|
| Visual Acuity | 2 | 2025 | 209 | 0.420 |
Why?
|
| Genome-Wide Association Study | 6 | 2018 | 1763 | 0.410 |
Why?
|
| Genetic Loci | 4 | 2018 | 260 | 0.390 |
Why?
|
| Kallikreins | 1 | 2012 | 46 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 61 | 0.380 |
Why?
|
| Alleles | 2 | 2016 | 1157 | 0.360 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 346 | 0.320 |
Why?
|
| Corynebacterium | 1 | 2025 | 10 | 0.230 |
Why?
|
| Biosynthetic Pathways | 1 | 2025 | 16 | 0.230 |
Why?
|
| Acute Pain | 1 | 2025 | 17 | 0.230 |
Why?
|
| Wet Macular Degeneration | 1 | 2025 | 22 | 0.230 |
Why?
|
| Depression, Postpartum | 1 | 2025 | 17 | 0.230 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2025 | 87 | 0.230 |
Why?
|
| Macular Edema | 1 | 2025 | 46 | 0.220 |
Why?
|
| Megakaryocytes | 1 | 2024 | 39 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 2 | 2025 | 992 | 0.220 |
Why?
|
| Diabetic Retinopathy | 1 | 2025 | 82 | 0.220 |
Why?
|
| Respiratory System | 1 | 2025 | 121 | 0.220 |
Why?
|
| Dengue Virus | 1 | 2024 | 49 | 0.220 |
Why?
|
| Dengue | 1 | 2024 | 51 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2024 | 60 | 0.220 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 32 | 0.210 |
Why?
|
| Analgesics | 1 | 2025 | 132 | 0.210 |
Why?
|
| Genome, Bacterial | 1 | 2025 | 159 | 0.210 |
Why?
|
| Proteome | 1 | 2025 | 156 | 0.210 |
Why?
|
| Blood Platelets | 1 | 2024 | 156 | 0.210 |
Why?
|
| Cesarean Section | 1 | 2025 | 157 | 0.210 |
Why?
|
| Protein Isoforms | 1 | 2024 | 297 | 0.200 |
Why?
|
| Pain Management | 1 | 2025 | 179 | 0.200 |
Why?
|
| Wounds, Gunshot | 1 | 2025 | 121 | 0.200 |
Why?
|
| Biological Products | 1 | 2025 | 179 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2025 | 186 | 0.190 |
Why?
|
| Suicide | 1 | 2024 | 162 | 0.180 |
Why?
|
| Influenza, Human | 1 | 2025 | 370 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2025 | 464 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2024 | 2059 | 0.180 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 632 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 513 | 0.160 |
Why?
|
| Mental Disorders | 1 | 2024 | 463 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 647 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 2494 | 0.150 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 52 | 0.140 |
Why?
|
| HLA Antigens | 1 | 2018 | 231 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2025 | 3974 | 0.120 |
Why?
|
| Female | 12 | 2025 | 50063 | 0.110 |
Why?
|
| Humans | 17 | 2025 | 96127 | 0.110 |
Why?
|
| Intravitreal Injections | 2 | 2025 | 83 | 0.110 |
Why?
|
| Antibodies, Bispecific | 2 | 2025 | 37 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 117 | 0.110 |
Why?
|
| Child | 6 | 2025 | 7626 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 152 | 0.110 |
Why?
|
| Male | 11 | 2025 | 45870 | 0.110 |
Why?
|
| Tomography, Optical Coherence | 2 | 2025 | 131 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 66 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 301 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 3927 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2025 | 407 | 0.100 |
Why?
|
| Genome, Human | 1 | 2018 | 824 | 0.100 |
Why?
|
| Genotype | 2 | 2016 | 1882 | 0.100 |
Why?
|
| Chimerism | 1 | 2013 | 38 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2025 | 299 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 84 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2014 | 713 | 0.090 |
Why?
|
| Adolescent | 5 | 2025 | 9896 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2883 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1083 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 547 | 0.080 |
Why?
|
| Infant | 3 | 2025 | 3363 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1133 | 0.080 |
Why?
|
| United States | 3 | 2025 | 7767 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2025 | 10286 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 1874 | 0.070 |
Why?
|
| Risk Factors | 2 | 2024 | 5960 | 0.070 |
Why?
|
| Logistic Models | 2 | 2025 | 1268 | 0.060 |
Why?
|
| Time Factors | 2 | 2025 | 5585 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2025 | 66 | 0.060 |
Why?
|
| Anesthesia, Spinal | 1 | 2025 | 17 | 0.060 |
Why?
|
| Fluorescein Angiography | 1 | 2025 | 83 | 0.060 |
Why?
|
| Nicaragua | 1 | 2024 | 3 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2025 | 172 | 0.060 |
Why?
|
| Multigene Family | 1 | 2025 | 213 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2025 | 134 | 0.050 |
Why?
|
| Risk | 2 | 2018 | 668 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2025 | 162 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 378 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2024 | 521 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 20964 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 3107 | 0.050 |
Why?
|
| Pregnancy | 2 | 2025 | 3240 | 0.050 |
Why?
|
| Young Adult | 2 | 2025 | 7025 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1958 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2025 | 361 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2025 | 9173 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2015 | 684 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 554 | 0.040 |
Why?
|
| Cytokines | 1 | 2025 | 872 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 935 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 28363 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 594 | 0.040 |
Why?
|
| Phenotype | 2 | 2018 | 2579 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1349 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2018 | 1423 | 0.040 |
Why?
|
| Microbiota | 1 | 2025 | 426 | 0.040 |
Why?
|
| Phylogeny | 1 | 2025 | 1275 | 0.040 |
Why?
|
| Genomics | 1 | 2025 | 855 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2025 | 2614 | 0.040 |
Why?
|
| Biomarkers | 1 | 2025 | 1933 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 777 | 0.030 |
Why?
|
| Allergens | 1 | 2018 | 191 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 4671 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 87 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2015 | 51 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 52 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 66 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 28718 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 7232 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 227 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 180 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 307 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 481 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 396 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 515 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2011 | 27 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1568 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1963 | 0.020 |
Why?
|
| North America | 1 | 2011 | 199 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1981 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4033 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1730 | 0.020 |
Why?
|